Bonde Artificial Heart Laboratory, Department of Surgery, Yale School of Medicine, New Haven, Conn.
Bonde Artificial Heart Laboratory, Department of Surgery, Yale School of Medicine, New Haven, Conn.
J Thorac Cardiovasc Surg. 2014 Jan;147(1):192-202. doi: 10.1016/j.jtcvs.2013.09.012. Epub 2013 Oct 29.
Rotary type left ventricular assist devices have mitigated the problem of durability associated with earlier pulsatile pumps and demonstrated improved survival. However, the compromise is the loss of pulsatility due to continuous flow and retained percutaneous driveline leading to increased mortality and morbidity. Lack of pulsatility is implicated in increased gastrointestinal bleeding, aortic incompetence, and diastolic hypertension. We present a novel, wirelessly powered, ultra-compact, implantable physiologic controller capable of running a left ventricular assist device in a pulsatile mode with wireless power delivery.
The schematic of our system was laid out on a circuit board to wirelessly receive power and run a left ventricular assist device with required safety and backup measures. We have embedded an antenna and wireless network for telemetry. Multiple signal processing steps and controlling algorithm were incorporated. The controller was tested in in vitro and in vivo experiments.
The controller drove left ventricular assist devices continuously for 2 weeks in an in vitro setup and in vivo without any failure. Our controller is more power efficient than the current Food and Drug Administration-approved left ventricular assist device controllers. When used with electrocardiography synchronization, the controller allowed on-demand customization of operation with instantaneous flow and revolutions per minute changes, resulting in a pulsatile flow with adjustable pulse pressure.
Our test results prove the system to be remarkably safe, accurate, and efficient. The unique combination of wireless powering and small footprint makes this system an ideal totally implantable physiologic left ventricular assist device system.
旋转式左心室辅助装置减轻了早期搏动泵相关的耐用性问题,并表现出了更好的存活率。然而,缺点是由于连续流动和保留的经皮驱动线导致丧失搏动,从而增加了死亡率和发病率。缺乏搏动与胃肠道出血、主动脉功能不全和舒张期高血压有关。我们提出了一种新颖的、无线供电的、超紧凑的、可植入的生理控制器,能够以无线供电的方式使左心室辅助装置以搏动模式运行。
我们的系统原理图被布置在电路板上,以无线方式接收电力并运行左心室辅助装置,同时采取了必要的安全和备份措施。我们嵌入了一个天线和无线网络用于遥测。纳入了多个信号处理步骤和控制算法。该控制器在体外和体内实验中进行了测试。
该控制器在体外设置和体内连续运行了 2 周,没有任何故障。我们的控制器比目前食品和药物管理局批准的左心室辅助装置控制器更节能。当与心电图同步使用时,该控制器允许按需定制操作,实现即时流量和每分钟转速变化,从而产生可调节脉冲压力的脉动流。
我们的测试结果证明该系统非常安全、准确和高效。无线供电和小尺寸的独特组合使该系统成为理想的完全可植入生理左心室辅助装置系统。